[go: up one dir, main page]

FI941538A7 - Partiklar, ett förfarande för framställning av dem och deras användnin g - Google Patents

Partiklar, ett förfarande för framställning av dem och deras användnin g Download PDF

Info

Publication number
FI941538A7
FI941538A7 FI941538A FI941538A FI941538A7 FI 941538 A7 FI941538 A7 FI 941538A7 FI 941538 A FI941538 A FI 941538A FI 941538 A FI941538 A FI 941538A FI 941538 A7 FI941538 A7 FI 941538A7
Authority
FI
Finland
Prior art keywords
particles
preparation
Prior art date
Application number
FI941538A
Other languages
English (en)
Finnish (fi)
Other versions
FI941538A0 (sv
FI941538L (sv
Inventor
Kåre Larsson
Tomas Landh
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Priority claimed from PCT/SE1992/000692 external-priority patent/WO1993006921A1/en
Publication of FI941538A0 publication Critical patent/FI941538A0/sv
Publication of FI941538A7 publication Critical patent/FI941538A7/sv
Publication of FI941538L publication Critical patent/FI941538L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00—Liquid crystal materials
    • C09K19/02—Liquid crystal materials characterised by optical, electrical or physical properties of the components, in general
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00—Liquid crystal materials
    • C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54—Additives having no specific mesophase characterised by their chemical composition
    • C09K19/542—Macromolecular compounds
    • C09K19/544—Macromolecular compounds as dispersing or encapsulating medium around the liquid crystal
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00—Liquid crystal materials
    • C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K2019/528—Surfactants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S516/00—Colloid systems and wetting agents; subcombinations thereof; processes of
    • Y10S516/90—Liquid crystal material of, or for, colloid system, e.g. g phase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Colloid Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI941538A 1991-10-04 1992-10-02 Partiklar, ett förfarande för framställning av dem och deras användning FI941538L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77101491A 1991-10-04 1991-10-04
PCT/SE1992/000692 WO1993006921A1 (en) 1991-10-04 1992-10-02 Particles, method of preparing said particles and uses thereof

Publications (3)

Publication Number Publication Date
FI941538A0 FI941538A0 (sv) 1994-03-31
FI941538A7 true FI941538A7 (sv) 1994-05-31
FI941538L FI941538L (sv) 1994-05-31

Family

ID=25090424

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941538A FI941538L (sv) 1991-10-04 1992-10-02 Partiklar, ett förfarande för framställning av dem och deras användning

Country Status (10)

Country Link
US (1) US5531925A (sv)
EP (1) EP0643620B1 (sv)
JP (1) JP3571717B2 (sv)
AT (1) ATE182278T1 (sv)
AU (1) AU2699892A (sv)
BR (1) BR9206593A (sv)
CA (1) CA2120359C (sv)
DE (1) DE69229640T2 (sv)
ES (1) ES2133391T3 (sv)
FI (1) FI941538L (sv)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2085827C (en) * 1991-12-23 2003-10-14 Lucas A. T. Hilgers Adjuvant composition containing synthetic hydrophobic lipopolysaccharide
US6277410B1 (en) 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
US6359054B1 (en) 1994-11-18 2002-03-19 Supratek Pharma Inc. Polynucleotide compositions for intramuscular administration
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
US6221959B1 (en) 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
US6040295A (en) * 1995-01-13 2000-03-21 Genemedicine, Inc. Formulated nucleic acid compositions and methods of administering the same for gene therapy
JPH08254688A (ja) * 1995-03-16 1996-10-01 Toshiba Corp 液晶表示素子
EP0840623B1 (en) 1995-07-21 2007-07-18 Brown University Research Foundation Compositions for gene therapy comprising nucleic acid loaded polymeric microparticles
US6248720B1 (en) * 1996-07-03 2001-06-19 Brown University Research Foundation Method for gene therapy using nucleic acid loaded polymeric microparticles
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
DE69608122T3 (de) * 1995-11-09 2011-06-16 Microbiological Research Authority Camr, Salisbury Mikroverkapselte dna zur impfung und gentherapie
US6284375B1 (en) * 1996-10-18 2001-09-04 Tuo Jin Lipid vesicle system
US20020182258A1 (en) * 1997-01-22 2002-12-05 Zycos Inc., A Delaware Corporation Microparticles for delivery of nucleic acid
US5783567A (en) * 1997-01-22 1998-07-21 Pangaea Pharmaceuticals, Inc. Microparticles for delivery of nucleic acid
US6106609A (en) * 1997-04-08 2000-08-22 The United States Of America As Represented By The Secretary Of The Navy Formation of nanocrystalline semiconductor particles within a bicontinuous cubic phase
DE69710442T2 (de) * 1997-05-02 2002-10-02 Takasago International Corp., Tokio/Tokyo Flüssigkristallphase enthaltende Lipidzusammensetzung
US5962015A (en) * 1997-05-02 1999-10-05 Kobo Products S.A.R.L. Stabilized liposomes
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
DE69816778T2 (de) 1997-09-09 2004-04-15 Lyotropic Therapeutics, Inc. Beschichtete teilchen, methode zu ihrer herstellung und verwendung
SE9703458D0 (sv) * 1997-09-25 1997-09-25 Pharmacia & Upjohn Ab Nicotine compositions and methods of formulation thereof
GB9810236D0 (en) 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents
US6406719B1 (en) 1998-05-13 2002-06-18 Microbiological Research Authority Encapsulation of bioactive agents
US6548302B1 (en) 1998-06-18 2003-04-15 Johns Hopkins University School Of Medicine Polymers for delivery of nucleic acids
US6916490B1 (en) 1998-07-23 2005-07-12 UAB Research Center Controlled release of bioactive substances
JP2002524741A (ja) * 1998-09-04 2002-08-06 パウダージェクト リサーチ リミテッド 粒子送達方法を使用する免疫診断
HUP0202299A3 (en) * 1999-08-06 2004-05-28 Max Delbrueck Centrum Implantable active ingredient depot
US20050037086A1 (en) * 1999-11-19 2005-02-17 Zycos Inc., A Delaware Corporation Continuous-flow method for preparing microparticles
KR20010100194A (ko) * 2000-03-13 2001-11-14 박호군 여러 가지 물질의 가용화용 조성물과 제형 및 그들의제조방법
US20040142475A1 (en) * 2000-06-02 2004-07-22 Barman Shikha P. Delivery systems for bioactive agents
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
US20040266983A1 (en) * 2000-08-17 2004-12-30 Reeve Lorraine E Purified polyoxyalkylene block copolymers
DE10057770A1 (de) * 2000-11-22 2002-05-23 Beiersdorf Ag Hautpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen ,
WO2002043696A1 (en) * 2000-11-29 2002-06-06 Lyotropic Therapeutics, Inc. Solvent systems for pharmaceutical agents
US7008646B2 (en) 2001-02-20 2006-03-07 Patrick Thomas Spicer Cubic liquid crystalline compositions and methods for their preparation
US6936187B2 (en) * 2001-02-21 2005-08-30 Matthew Lawrence Lynch Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
US6656385B2 (en) * 2001-02-21 2003-12-02 The Procter & Gamble Company Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
US20030060695A1 (en) * 2001-03-07 2003-03-27 Connelly Patrick R. Implantable artificial organ devices
US6991809B2 (en) * 2001-06-23 2006-01-31 Lyotropic Therapeutics, Inc. Particles with improved solubilization capacity
GB0118300D0 (en) * 2001-07-26 2001-09-19 Cortendo Ab Formulations
US6746635B2 (en) * 2001-08-08 2004-06-08 Brown University Research Foundation Methods for micronization of hydrophobic drugs
US20040022820A1 (en) * 2001-11-28 2004-02-05 David Anderson Reversed liquid crystalline phases with non-paraffin hydrophobes
CA2469718A1 (en) * 2001-12-10 2003-06-19 Spherics, Inc. Methods and products useful in the formation and isolation of microparticles
WO2003090693A2 (en) * 2002-04-23 2003-11-06 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing lamotrigine particles of defined morphology
US20040018237A1 (en) * 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
CA2488643A1 (en) * 2002-06-13 2003-12-24 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
US20030232340A1 (en) * 2002-06-13 2003-12-18 David Anderson Nanoporous particle with a retained target
WO2004012680A2 (en) * 2002-08-06 2004-02-12 Lyotropic Therapeutics, Inc. Lipid-drug complexes in reversed liquid and liquid crystalline phases
GB0305941D0 (en) * 2003-03-14 2003-04-23 Camurus Ab Composition
US20050119340A1 (en) * 2003-06-13 2005-06-02 David Anderson Treatment methods with low-dose, longer-acting formulations of local anesthetics and other agents
JP5180474B2 (ja) * 2003-08-04 2013-04-10 カムルス エービー 両親媒性粒子の特性を改良する方法
US20070108405A1 (en) * 2003-09-01 2007-05-17 Fh Faulding & Co., Ltd. Compositions and methods for delivery of biologically active agents
GB0322033D0 (en) * 2003-09-19 2003-10-22 Camurus Ab Composition
US20070293441A1 (en) * 2003-09-22 2007-12-20 Baxter International Inc. High-pressure sterilization to terminally sterilize pharmaceutical preparations and medical products
CN1905905B (zh) 2003-09-22 2011-06-08 巴克斯特国际公司 用于药物制剂和医药产品最终灭菌的高压灭菌
US7713440B2 (en) * 2003-10-08 2010-05-11 Lyotropic Therapeutics, Inc. Stabilized uncoated particles of reversed liquid crystalline phase materials
US8865021B2 (en) * 2003-11-07 2014-10-21 Camurus Ab Compositions of lipids and cationic peptides
US8182834B2 (en) 2004-01-23 2012-05-22 Camurus Ab Ternary non-lamellar lipid compositions
GB0401513D0 (en) * 2004-01-23 2004-02-25 Camurus Ab Compositions
EP1598060A1 (en) * 2004-05-18 2005-11-23 Nestec S.A. Oil-in-water emulsion for delivery
EP1778187B1 (en) * 2004-08-04 2012-05-23 Camurus Ab Compositions forming non-lamellar dispersions
GB0417388D0 (en) * 2004-08-04 2004-09-08 Camurus Ab Composition
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
KR100983746B1 (ko) * 2005-01-14 2010-09-24 카무러스 에이비 소마토스타틴 유사 제형
US9649382B2 (en) 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
US8871712B2 (en) * 2005-01-14 2014-10-28 Camurus Ab Somatostatin analogue formulations
PL2206495T3 (pl) 2005-01-14 2013-05-31 Camurus Ab Bioadhezyjne formulacje do stosowania miejscowego
WO2006077362A1 (en) * 2005-01-21 2006-07-27 Camurus Ab Pharmaceutical lipid compositions
GB0501364D0 (en) * 2005-01-21 2005-03-02 Camurus Ab Compositions
US7125954B2 (en) 2005-01-27 2006-10-24 General Electric Company Method for producing polyether polymers
JP5198261B2 (ja) * 2005-06-06 2013-05-15 カムルス エービー Ｇｌｐ−１類似体製剤
RU2318947C2 (ru) * 2006-02-28 2008-03-10 Московский автомобильно-дорожный институт (Государственный технический университет) Способ устройства дорожного покрытия
WO2008034082A2 (en) * 2006-09-15 2008-03-20 Maroon Biotech, Corporation Method of using amphiphilic multiblock copolymers in food
CZ299218B6 (cs) * 2006-11-07 2008-05-21 Zentiva, A. S. Kompozice depotních olanzapinových injekcních systému
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
JP2008120838A (ja) * 2008-02-21 2008-05-29 Medgel Corp 配位結合を利用した薬物−高分子複合体製剤の調製方法
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
WO2010063080A1 (en) * 2008-12-05 2010-06-10 Commonwealth Scientific And Industrial Research Organisation Amphiphile prodrugs
US9080973B2 (en) * 2009-04-22 2015-07-14 Wisconsin Alumni Research Foundation Analyte detection using liquid crystals
CN104427977B (zh) * 2012-05-10 2018-02-02 佩因拉佛姆有限公司 局部麻醉剂的储库制剂及其制备方法
SG11201407678YA (en) 2012-05-25 2014-12-30 Camurus Ab Somatostatin receptor agonist formulations
SI3122799T1 (sl) * 2014-03-25 2020-06-30 F. Hoffmann-La Roche Ag Metode priprave poloksamera za uporabo v gojišču za celične kulture
CN107205956A (zh) 2014-10-30 2017-09-26 纺织品技术股份有限公司 输送系统
US12503483B2 (en) 2018-04-26 2025-12-23 NanoMed Holdings Pty Ltd Gemcitabine amphiphile prodrugs
US12194014B2 (en) 2018-06-21 2025-01-14 NanoMed Holdings Pty Ltd Platinum-based amphiphile prodrugs
WO2020219825A1 (en) 2019-04-24 2020-10-29 Cornell University Systems, compositions, and methods for evaluating biomechanical properties of cells
BR112022015321A2 (pt) 2020-02-03 2022-09-20 Curemast Inc Composição e método para tratamento de mastite e método de tratamento de mastite em uma vaca ou cabra leiteira

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
US4556289A (en) * 1983-03-21 1985-12-03 Manchester R & D Partnership Low birefringence encapsulated liquid crystal and optical shutter using same
US5371109A (en) * 1986-07-01 1994-12-06 Drilletten Ab Controlled release composition for a biologically active material dissolved or dispersed in an L2-phase
GB8803037D0 (en) * 1988-02-10 1988-03-09 Unilever Plc Aqueous detergent compositions & methods of forming them
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5143934A (en) * 1990-11-21 1992-09-01 A/S Dumex (Dumex Ltd.) Method and composition for controlled delivery of biologically active agents
JPH03139525A (ja) * 1989-10-24 1991-06-13 Sunstar Eng Inc 紫外線硬化性組成物

Also Published As

Publication number Publication date
CA2120359C (en) 2000-12-26
JP3571717B2 (ja) 2004-09-29
US5531925A (en) 1996-07-02
DE69229640T2 (de) 1999-12-16
CA2120359A1 (en) 1993-04-15
JPH07502197A (ja) 1995-03-09
ES2133391T3 (es) 1999-09-16
FI941538A0 (sv) 1994-03-31
BR9206593A (pt) 1995-11-28
DE69229640D1 (de) 1999-08-26
EP0643620A1 (en) 1995-03-22
ATE182278T1 (de) 1999-08-15
EP0643620B1 (en) 1999-07-21
FI941538L (sv) 1994-05-31
AU2699892A (en) 1993-05-03

Similar Documents

Publication Publication Date Title
FI941538A7 (sv) Partiklar, ett förfarande för framställning av dem och deras användnin g
FI924054A7 (sv) Iso- och heterocykliska föreningar kopplade med imidazol, förfarande för framställning av dessa och användning av dessa
FI941137L (sv) 2-debensoyl-2-acyltaxolderivat och förfaranden för framställning av dessa
FI952179A7 (sv) Nya 3,3-difenylpropylaminer, användning och framställning därav
FI935465L (sv) Termoplastisk komposition, foerfarande foer framstaellning av denna och anvaendning av denna
FI951468A7 (sv) Lipopeptidderivat, förfarande för framställning och användning av desamma
FI931499A7 (sv) Cyklopeptider, förfarande för deras framställning och deras användning såsom läkemedel
MX9201355A (es) Bis-naftal imidas y metodo para su preparacion.
FI934141A7 (sv) Antikogulanter och förfaranden för framställning av dessa
FI945837L (sv) Mikropartiklar, förfarande för framställning av dem och användning av dem i diagnostik
FI922875A7 (sv) Föreningar med reninhämmande egenskaper, förfarande för deras framställning och deras användning
FI902629A7 (sv) Aryloxyfenylpropylaminer, deras framställning och användning
FI921525A7 (sv) Amidinofenylalaninderivat, förfarande för deras framställning, deras användning och dessa innehållande ämnen
FI900461A7 (sv) Imidazopyridaziner, deras framställning och användning
FI940775L (sv) Förfarande för framställning av alfa-fenylisoserinderivat och användning av dem
FI911615A7 (sv) Nya 4-kinolyl-dihydropyridiner, förfaranden för deras framställning och deras användning i läkemedel
FI910696A7 (sv) SiO2-opaliseringsämne, förfarande för dess framställning samt användning av detsamma
FI891812L (sv) Sammansättning som dödar mikro-organismer/hindrar tillväxten av mikroorganismer och förfarande för framställning av en sådan
FI951631L (sv) Substituerade kynureniner, förfarande för deras framställning och använding av desamma som läkemedel
FI923755A7 (sv) Disulfider, förfarande för framställning av dessa och användning av dessa
FI934680A7 (sv) Arylmorfolin, framställning och använding
FI941914A7 (sv) 2-amino-4-kinolindihydropyridiner, förfaranden för framställning av dessa och användning av dessa
FI930716A7 (sv) Nya arylkarbonylaminoalkyldihydrooxopyridiner, framställning och användning av dessa
FI900627A7 (sv) 2,3,23-trihydroxiurs-12-en och dess derivat, förfarande för deras framställning och deras användning
FI934395A7 (sv) 2-spirocyklopropyl 4-acylcephemi samt förfarande för framställning där av

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: GS DEVELOPMENT AB